lung
Washington (AFP) - A Pfizer medicine has been shown to greatly reduce cancer progression and improve survival outcomes for people in the advanced stages of a form of lung cancer, results published Friday showed. Lorlatinib, which is already approved and available under the brand name Lobrena in the United States, was tested in a clinical trial of hundreds of people with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). Roughly half received lorlatinib while the rest received crizotinib, an earlier generation drug. After five years of follow-up time, more th...
AFP
How did deadly wildfires in Hawaii last year impact people's health? A new study found that nearly half of people in Maui affected by the fires "experienced a decline in health," compared to a year ago. Roughly 74 per cent of study participants had poor respiratory health or elevated risk for cardiovascular disease due to hypertension. The University of Hawaii study looked at 679 people as part of ongoing research into the impact of the fires on health. More than half of the participants lived in the fire perimeter area. Heat-related deaths are on the rise in Europe as the effects of climate c...
Euronews (English)
Tiny particles of plastic pollution could be finding their way deep into our lungs with every breath we take, new research reveals. Known as microplastics or nanoplastics, a study from the University of Technology Sydney has used complex computer models to find out what happens when we breathe these particles and where in our bodies they end up. “Plastic particle air pollution is now pervasive and inhalation ranks as the second most likely pathway for human exposure,” says lead author Dr Suvash Saha. Oral intake, or in other words eating and drinking them, is the most common exposure route. He...
Euronews (English)
Washington (AFP) - US doctors announced Thursday they had successfully performed a double lung transplant on a patient with terminal lung cancer, giving new hope to others who also have advanced stages of the deadly disease. Albert Khoury, a 54-year-old non-smoker, underwent a seven-hour surgery to receive his new lungs at Northwestern Medicine in Chicago on September 25, 2021. Six months on, the lungs are working well and he has no signs of cancer in his body. "Lung transplantation for lung cancer is extremely uncommon with few cases reported," Ankit Bharat, chief of thoracic surgery at Nort...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら